Dr. Rick Zeifman joined the NYU Langone Center for Psychedelic Medicine in 2022, as the first post-doctoral fellow accepted to the Psychedelic Medicine Research Training Program. His research focuses on integrating psychotherapies with novel pharmacological interventions (including psychedelics), and using a multi-method approach to examine the mechanisms of change in psychotherapy. Dr. Zeifman has experience providing evidenced-based psychotherapies for individuals with a range of clinical presentations (e.g., post-traumatic stress disorder, anxiety disorders, and borderline personality disorder). He is a study therapist in an ongoing clinical trial examining MDMA-facilitated cognitive processing therapy for participants with PTSD. Before joining the CPM, Dr. Zeifman earned his PhD in Clinical Psychology at the Toronto Metropolitan University, and his clinical residency at the Centre for Addiction and Mental Health.